Latest News about Psychedelics
Recent news which mentions Psychedelics
From Benzinga
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards
November 20, 2024
From Benzinga
DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
November 20, 2024
Tickers
NEWS
From Benzinga
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
From Benzinga
From Benzinga
From Benzinga
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
From Benzinga
Medical Cannabis And Legal Cocaine: The Unusual Permit That Puts Border Laws In Check
November 16, 2024
From Benzinga
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
November 15, 2024
From Benzinga
Numinus Wellness Sells US Clinics, Partners With Stella For Tech-Driven Mental Health Solutions
November 15, 2024
From Benzinga
Trump-Appointed Doug Collins To Lead VA: What's Next For Cannabis and Psychedelics In Veterans' Healthcare?
November 15, 2024
Tickers
NEWS
From Benzinga
New Study Charts Adverse Events In Psychedelic-Assisted Therapies
November 14, 2024
Tickers
NEWS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
